Pentixapharm Holding AG/€PTP
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Pentixapharm Holding AG
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company specializing in the development of targeted radiopharmaceuticals for diagnostic and therapeutic applications. Its core products include PentixaFor, a Gallium-68-based tracer for diagnosing hematological and solid tumors, and PentixaTher, a Yttrium-90-based therapeutic agent for treating non-Hodgkin lymphomas. Founded in 2019 and headquartered in Berlin, Germany, the company operates additional offices in Würzburg. In July 2024, Pentixapharm acquired Glycotope's target discovery business, enhancing its pipeline with preclinical antibodies against multiple oncology targets. The company's strategic focus on CXCR4 ligand-based radiopharmaceuticals positions it to address a range of cancers and other diseases. (,)
Ticker
€PTP
Sector
Primary listing
XETRA
Industry
Health Care Equipment and Supplies
Headquarters
Employees
70
Website
PTP Metrics
BasicAdvanced
€49M
-
-€0.68
-
-
Price and volume
Market cap
€49M
52-week high
€2.97
52-week low
€1.88
Average daily volume
22K
Financial strength
Current ratio
3.14
Quick ratio
2.792
Interest coverage (TTM)
-201.92%
Profitability
EBITDA (TTM)
-9.728
Gross margin (TTM)
-3,500.73%
Net profit margin (TTM)
-12,303.65%
Operating margin (TTM)
-7,811.68%
Effective tax rate (TTM)
18.42%
Management effectiveness
Return on assets (TTM)
-10.75%
Return on equity (TTM)
-36.80%
Valuation
Price to revenue (TTM)
365.659
Price to book
1.09
Price to tangible book (TTM)
4.75
Price to free cash flow (TTM)
-4.924
Free cash flow yield (TTM)
-20.31%
Free cash flow per share (TTM)
-0.41
Growth
Revenue change (TTM)
-97.93%
Earnings per share change (TTM)
96.95%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Pentixapharm Holding AG stock?
Pentixapharm Holding AG (PTP) has a market cap of €49M as of July 30, 2025.
What is the P/E ratio for Pentixapharm Holding AG stock?
The price to earnings (P/E) ratio for Pentixapharm Holding AG (PTP) stock is 0 as of July 30, 2025.
Does Pentixapharm Holding AG stock pay dividends?
No, Pentixapharm Holding AG (PTP) stock does not pay dividends to its shareholders as of July 30, 2025.
When is the next Pentixapharm Holding AG dividend payment date?
Pentixapharm Holding AG (PTP) stock does not pay dividends to its shareholders.
What is the beta indicator for Pentixapharm Holding AG?
Pentixapharm Holding AG (PTP) does not currently have a Beta indicator.